By Maria Kalamatas – June 21, 2025
Location: São Paulo, Brazil

A silent boom at the airport gates
At Guarulhos International Airport, an unusual calm hides a growing shift. In a newly built cold chain terminal, pharmaceutical shipments—vaccines, insulin, lab reagents—are processed under strict temperature controls, ready for export to Europe, North America, and the Gulf.

This week, Brazil inaugurated three GDP-certified cargo facilities across São Paulo, Campinas, and Recife, all part of a national plan to boost the country’s position as a reliable source for temperature-sensitive goods.

“We used to be seen only as a raw materials hub,” said Carla Meneses, logistics director for BioNova, a local pharmaceutical exporter. “Now we’re shipping finished medical products globally—and on schedule.”

Infrastructure catching up with industry
Brazil’s pharma industry has grown quietly but steadily, driven by domestic innovation and international licensing. Exports rose by 18.3% year-on-year in Q1 2025, according to data from ANVISA, the national health agency. But until recently, the logistics to support this growth were patchy at best.

With help from public-private partnerships, airports are now equipped with modern handling systems, controlled-temperature storage, and digital traceability platforms. LATAM Cargo and Emirates SkyCargo are among the carriers expanding weekly services for pharma cargo out of Brazil.

“We no longer have to route critical shipments through Miami or Madrid,” said Meneses. “We have viable gateways here, in-country.”

A shift in reputation—and opportunity
Brazil’s logistics sector has often been criticized for its complexity and delays. But the country’s growing success in managing pharmaceutical exports—where delays can destroy entire shipments—suggests a deeper transformation.

International clients are taking note. A European biotech firm recently signed a long-term supply deal with a Brazilian lab, contingent on the new cold chain routes operating within a 72-hour delivery window.

“That would’ve been unthinkable five years ago,” said João Freitas, trade consultant at the São Paulo Export Forum. “What’s changed isn’t just infrastructure—it’s confidence.”

Looking ahead: air cargo leads the way
The expansion of GDP-certified facilities is part of Brazil’s broader plan to triple high-value cargo exports by 2030. With a focus on healthcare, biotech, and precision agriculture, the sector is being treated as a pillar of the next export cycle.

An intermodal strategy is also in motion, linking São Paulo’s cargo hubs to the Port of Santos and regional airports via dedicated freight corridors. That means pharmaceuticals won’t just fly—they’ll move overland and by sea, safely and traceably.

Conclusion
Brazil’s cargo story is changing. Once associated with delays and informal networks, it’s now becoming a case study in controlled growth and logistics specialization. If the momentum continues, the country could soon become a reference point—not just in exports, but in trust.

The post “Brazil’s Pharma Cargo Exports Surge as New Cold Chain Facilities Go Live” appeared first on The Logistic News.